DABIGATRAN ETEXILATE VIATRIS 110 MG CPS DUR 60

Show dosage form

What is the maximum co-payment for DABIGATRAN ETEXILATE VIATRIS?

If the insurance company contributes, the maximum co-payment is 1 482,36 Kč. The maximum pharmacy price is 1 816,79 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price. If the physician marks increased reimbursement on the prescription, the maximum co-payment is 1 482,79 Kč.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does DABIGATRAN ETEXILATE VIATRIS have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

334,43 Kč.

Does the insurance company pay a higher amount in some cases?

Yes, increased reimbursement exists. A physician with the required specialization may, under strictly defined conditions, set a second reimbursement of 334,00 Kč.

Does the medicine have an indication restriction?

Přípravek je v ambulantní péči hrazen v primární prevenci žilních tromboembolií u dospělých pacientů, kteří podstoupili elektivní operativní totální náhradu kyčelního nebo kolenního kloubu. Maximální celková doba podávání hrazená ze zdravotního pojištění po elektivní náhradě kolenního kloubu je 14 dní, po elektivní náhradě kyčelního kloubu 28-35 dní.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe DABIGATRAN ETEXILATE VIATRIS?

Prescription is not conditional on a medical specialization.

What is the composition of DABIGATRAN ETEXILATE VIATRIS?

Dabigatran-etexilát-mesilát (126,83 mg), dabigatran-etexilát (110 mg), neznámá látka s kódem 1833, hypromelosa, ointmentek, neznámá látka s kódem 4336, oxid titaničitý, neznámá látka s kódem 4535, šelak, propylenglykol, neznámá látka s kódem 9970, černý oxid železitý, hydroxid draselný. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to DABIGATRAN ETEXILATE VIATRIS?

The medicine belongs to ATC group B01AE07 – DABIGATRAN-ETEXILÁT. Medicines with the same active substance can be found here.

Who manufactures DABIGATRAN ETEXILATE VIATRIS?

VIATRIS LIMITED, Dublin (IRL)

Is the medicine in shortage?

The latest report from the manufacturer is from 4. 3. 2025. Production was terminated with effect from 1. 5. 2025. The manufacturer lists medicines with the following code as a potential substitute:

What is the unique code for DABIGATRAN ETEXILATE VIATRIS?

The medicine has code 0270286. Code details can be found here.

How many packs of DABIGATRAN ETEXILATE VIATRIS were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of DABIGATRAN ETEXILATE VIATRIS were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

PODOBNÉ PŘÍPRAVKY:

The page was last updated on 01. 04. 2026

SIMILAR MEDICINES: